Finally, we evaluated long-term functional outcomes at twelve months and at the last clinical follow-up visit, with a median of 5.1 years post-stroke in the > 5 mg/l CRP group and 1.4 years in the ≤ 5 mg/l CRP group using the mRS score92. The gene discussed is CRP; the disease is Stroke.